Pharmacological neuroplasticity enhancement works—but only when it complements physical therapy, not replaces it

We have been searching for drugs that speed stroke recovery for decades. SSRIs, ampakines, BDNF modulators—all showed promise in rodent models. The clinical results have been disappointing.
The problem is not that these drugs do not work. It is that we have been testing them wrong.